Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
Omslag van het boek

2014 | OriginalPaper | Hoofdstuk

123. Gastro-oesofageale reflux bij kinderen van 0-18 maanden

Auteur : Hannebeth Bosker

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

Bij reflux is er terugvloed van maaginhoud in de slokdarm, met of zonder regurgitatie en spugen. Indien dit gepaard gaat zonder klachten, wordt gesproken van gastro-oesofageale reflux (GOR). Van gastro-oesofageale refluxziekte (GERZ) wordt gesproken als de GOR leidt tot hinderlijke klachten of complicaties bij de zuigeling, zoals prikkelbaar gedrag, voedselweigering, groeivertraging, het opgeven van bloedsliertjes, slaapproblemen of apparent life-threatening events.
Literatuur
1 Allen K, Ho SSC. Gastro-oesophageal reflux in children, what’s the worry. Aust Fam Physician 2012;41:268-72.
2 Blanco FC, Davenport KP, Kane TD. Pediatric gastroesophageal reflux disease. Surg Clin North Am 2012;92:541-58.CrossRef
4 Martigne L, Delaage PH, Thomas-Delecourt F, Bonnelye G, Barthélémy P, Gottrand F. Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study. Eur J Pediatric 2012;171:1767-73.CrossRef
5 Nielen MMJ, Spronk I, Davids R, Zwaanswijk M, Verheij RA, Korevaar JC. Incidentie en prevalentie van gezondheidsproblemen in de Nederlandse huisartsenpraktijk in 2014: NIVEL Zorgregistraties eerste lijn [internet]. Utrecht: NIVEL; 2015-2016. www.​nivel.​nl/​node/​4309, geraadpleegd april 2016.
6 Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pedicatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroent Nutr 2009;49:498-547.CrossRef
7 Oyen N, Markestad T, Skaerven R, et al. Combined effects of sleeping position and prenatal risk factors in sudden infant death syndrome: the Nordic Epidemiological SIDS Study. Pediatrics 1997; 100:613-21.CrossRef
9 Tighe M, Afzal NA, Bevan A, Hayen A, Munro A, Beattie RM. Pharmacological treatment of children with gastrooesophageal reflux. Cochrane Database Syst Rev 2014;(11):CD008550.
10 Tobin JM, McCloud P, Cameron DJ. Posture and gastro-oesophageal reflux: a case for left lateral positioning. Arch Dis Child 1997;76:254-8.CrossRef
11 Meyers WF, Herbst JJ. Effectiveness of positioning therapy for gastroesophageal reflux. Pediatrics 1982;69:768-72.
12 Orenstein SR, Whitington PF, Orenstein DM. The infant seat as treatment for gastroesophageal reflux. N Engl J Med 1983;309:760-3.CrossRef
13 Loots C, Kritas S, van Wijk M, McCall L, Peeters L, Lewindon P, et al. Body positioning and medical therapy for infantile gastroesophageal reflux symptoms. J Pediatr Gastroenterol Nutr 2014;59:237-43.CrossRef
14 Jung WJ, Yang HJ, Min TK, Jeon YH, Lee HW, Lee JS, èt al. The efficacy of the upright position on gastro-esophageal reflux and reflux-related respiratory symptoms in infants with chronic respiratory symptoms. Allergy Asthma Immunol Res 2012;4:17-23.CrossRef
15 Bagucka B, De Schepper J, Peelman M, Van de Maele K, Vandenplas Y. Acid gastro-esophageal reflux in the 10 degrees-reversed-Trendelenburg-position in supine sleeping infants. Acta Paediatr Taiwan 1999;40:298-301.
16 Craig WR, Hanlon-Dearman A, Sinclair C, Taback S, Moffatt M. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev 2004;(4):CD003502.
17 Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and metaanalysis of randomized, controlled trials. Pediatrics 2008;122:e1268-77.CrossRef
18 Orenstein SR, Shalaby TM, Devandry SN, et al. Famotidine for infant gastrooesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial. Aliment Pharmacol Ther 2003;17:1097-107.CrossRef
19 Orenstein SR, Gremse DA, Pantaleon CD, Kling DF, Rotenberg KS. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Clin Ther 2005;27:472-83.CrossRef
20 Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007;44(1):41-4.CrossRef
21 Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514-20.CrossRef
22 Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr 2003;143:219-23.CrossRef
23 Davidson G, Wenzl TG, Thomson M, Omari T, Barker P, Lundborg P, Illueca M. Efficacy and safety of oncedaily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. J Pediatr 2013;163:692-8.CrossRef
24 Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M. Esomeprazole for the treatment of GERD in infants aged 1-11 months. J Pediatr Gastroenterol Nutr 2015;60 Suppl 1:S9-15.CrossRef
25 Omari T, Davidson G, Bondarov P, Nauclér E, Nilsson C, Lundborg P. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2015;60 Suppl 1:S2-8.CrossRef
26 Ummarino D, Miele E, Martinelli M, et al. Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants. J Pediatr Gastroenterol Nutr 2015;60:230-5.CrossRef
27 Gilger MA, Tolia V, Vandenplas Y, Youssef NN, Traxler B, Illueca M. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2015;60 Suppl 1:S16-23.
28 Gieruszczak-Bialek D, Konarska Z, Skórka A, Vandenplas Y, Szajewska H. No effect of proton pump inhibitors on crying and irritability in infants: systematic review of randomized controlled trials. J Pediatr 2015;166:767-70.CrossRef
29 Cohen S, Bueno de Mesquita M, Mimouni FB. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review. Br J Clin Pharmacol 2015;80:200-8.CrossRef
30 Van Ginderdeuren F, Kerckhofs E, Deneyer M, Vanlaethem S, Vandenplas Y. Influence of respiratory physiotherapy on gastro-oesophageal reflux in infants: A systematic review. Pediatr Pulmonol 2015;50:936-44.
Metagegevens
Titel
Gastro-oesofageale reflux bij kinderen van 0-18 maanden
Auteur
Hannebeth Bosker
Copyright
2014
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-1696-0_123